Text Size

Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years (Pneumococci)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by King Saud University.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
King Saud University
ClinicalTrials.gov Identifier:
NCT00843895
First received: February 9, 2009
Last updated: February 11, 2009
Last verified: February 2009
History of Changes
  Purpose

The purpose of this study is to identify the S. pneumoniae serotypes strains and to determine antibiotic susceptibility.


Condition Intervention
Pneumococcal Disease
 Biological: pneumococcal conjugate vaccine(prevenar)

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Screening
Official Title: Serotyping of Pneumococci

Resource links provided by NLM:

MedlinePlus related topics: Antibiotics
U.S. FDA Resources

Further study details as provided by King Saud University:

Primary Outcome Measures:
  • Incidence and serotypes of invasive pneumococcal dis. [ Time Frame: 6-8 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Antibiotic susceptibility [ Time Frame: 6-8 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 400
Study Start Date: March 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Biological: pneumococcal conjugate vaccine(prevenar)
    to see the vaccine impact on pneumococcal diseases
  Eligibility

Ages Eligible for Study:   up to 5 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age less than 5 years

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00843895

Contacts
Contact: Atef M. Shibl, PH D 00966505 30 2775 amshibl@ksu.edu.sa

Sponsors and Collaborators
King Saud University
  More Information

No publications provided

Responsible Party: King saud university, wyeth
ClinicalTrials.gov Identifier: NCT00843895     History of Changes
Other Study ID Numbers: kingsadu
Study First Received: February 9, 2009
Last Updated: February 11, 2009
Health Authority: Saudi Arabia: Research Advisory Council

Keywords provided by King Saud University:
Laboratory based study
antibiotic susceptibilty
invasive strains

ClinicalTrials.gov processed this record on May 22, 2013